New program aims to ease Parents' grief after devastating prenatal diagnosis
NCT ID NCT06456034
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This pilot study tests a new perinatal palliative care program for parents who receive a life-limiting diagnosis for their unborn or newborn baby. The program includes a dedicated care team, specialized training, and structured support. Researchers will enroll 20 parents and their healthcare providers to see if the program is feasible and helpful, measuring pain, grief, and satisfaction.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Perinatal palliative care program (behavioral intervention)
What this could lead to
If it works, this could lead to a standardized way to provide emotional and practical support to parents and healthcare providers during a very difficult time.
What could go wrong
This is a very small pilot study (20 participants) testing feasibility, not effectiveness. The results may not apply to all hospitals or families.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERINATAL PALLIATIVE CARE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UZ Brussels
RECRUITINGBrussels, 1090, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
UZ Gent
NOT_YET_RECRUITINGGhent, 9000, Belgium
Contact Phone: •••-•••-•••• Email: •••••@•••••